Neoadjuvant OX40 therapy in patients with head and neck cancer induces profound changes in tumor-infiltrating lymphocytes
Work
Year: 2018
Type: article
Source: The Journal of Immunology
Authors Rebekka Duhen, Carmen BallesterosāMerino, R. Bryan Bell, Rom S. Leidner, Yoshinobu Koguchi +3 more
Institutions Providence Portland Medical Center, Providence College
Cites:
Cited by: 4
Related to: 10
FWCI: 0.315
Citation percentile (by year/subfield): 60.36
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: closed